[indices] Summaries from the AidsMap bulletin

["Libby Levison" <libby@theplateau.com>]

Summaries from the AidsMap bulletin
-------------------------

AidsMap -- it's a useful e-bulletin for anyone working on ART:  www.aidsmap.com

 **Generic efavirenz-based regimens provide effective viral load suppression

http://www.aidsmap.com/en/news/4A890EA5-08DA-41B3-9D41-1549F310F44D.asp?wk=1

 HAART regimens including generic efavirenz provide effective suppression of
 viral load, increase CD4 cell counts, and are safe and well tolerated,
 according to a study conducted in southern India and published in the April
 8th edition of AIDS. The investigators write that the results of their
 study "are comparable to findings in clinical trials and prospective
 studies on proprietary efavirenz."


 **European warning about tenofovir/ddI, and BMS strengthens caution about
 use of efavirenz during pregnancy

http://www.aidsmap.com/en/news/F1F997E0-6E4F-4160-B866-A9D2A335E43B.asp?wk=1

 Tenofovir (Viread) and ddI (Videx) should not be used together, European
 medicine regulatory authorities have warned in a public statement. The
 caution follows a "Dear Doctor" letter issued by Gilead Sciences and
 Bristol Myers Squibb (BMS), the manufacturers of the drugs last month.

Libby Levison
Public Health Consultant
libby@theplateau.com